Cookie and data protection information

This website uses cookies & third-party applications to enable certain functions and to improve the offer.

Schützt vor Cross-Site-Request-Forgery Angriffen.

Retention period: Dieses Cookie bleibt nur für die aktuelle Browsersitzung bestehen.

Speichert die aktuelle PHP-Session.

Retention period: Dieses Cookie bleibt nur für die aktuelle Browsersitzung bestehen.

Third party applications for analysis purposes for our website

Provider: Google Ireland Ltd., Gordon House, Barrow Street, Dublin 4, Ireland
Retention period: More about sessions duration https://policies.google.com/privacy.
Data Protection
MiGenTra
Skip navigation
  • Company
  • Products
  • News
  • Careers
  • Contact
  • Company
    • Mission
    • History
    • Strategy
    • Facilities
    • Management
  • Products
    • Biosimilars
    • Cell and Gene Therapies (CGT)
    • Vaccines
    • Contact
  • News
    • Announcements
    • Press Release
    • Media & Downloads
  • Careers
    • Quality Assurance Manager (f/m/d)
    • Marketing & Communication Manager (f/m/d)
  • Contact
    • General Contact
    • Legal Notice
    • Disclaimer
    • Data Protection

Press Releases

Mar 06, 2023

Participants Dosed on Adessia® in Germany in a Phase 1 Trial, a First for an Adalimumab Biosimilar Candidate Developed in Africa

read more

  • download PDF

Nov 29, 2022

Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa

read more

  • download PDF

Nov 03, 2022

MiGenTra Highlights How Biosimilars Are Transforming Healthcare in Africa at the Festival of Biologics

read more

  • download PDF

May 18, 2022

MiGenTra Marks One-Year Anniversary by Attending Africa Health ExCon 2022

read more

  • download PDF

Mar 07, 2022

Lutz Hilbrich Appointed as Senator to the Senate of Economy Europe

read more

  • download PDF

Mar 02, 2022

Product Development Company MiGenTra Announces Formation of International Advisory Board

read more

  • download PDF

May 27, 2021

ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH – A Healthcare Transforming Medicines Company

read more

  • download PDF

Media & Downloads

MiGenTra White Paper: How Biosimilars are Transforming Healthcare

White Paper: How Biosimilars are Transforming Healthcare

read more

  • download PDF
Corporate Presentation

Company Slide Deck

  • download PDF

News

Skip navigation
  • Announcements
  • Press Release
  • Media & Downloads

Press Contact

Sarah Wandrey, Corporate Communications

Sarah Wandrey
Corporate Communications
Phone: +49 (0) 30 3229 35 144
Email: press@probiogen.de

MiGenTra GmbH

  • Headquarters
  • Herbert-Bayer-Straße 4
  • 13086 Berlin, Germany
  • Phone: +49 (0) 30 5771 4380
  • Email: info@migentra.com
Follow us

Copyright © 2021 MiGenTra GmbH
Legal Notice | Disclaimer | Data Protection